Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients

Cytokine

Volumn 66, Issue 2, 2014, Pages 119-126

  Galati, Domenico ^a   De Martino, Marina ^b   Trotta, Annamaria ^a   Rea, Gaetano ^c   Bruzzese, Dario ^b   Cicchitto, Gaetano ^d   Stanziola, Anna Agnese ^b   Napolitano, Maria ^a   Sanduzzi, Alessandro ^b   Bocchino, Marialuisa ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

^d ASL   (Italy)

Author keywords

Flow cytometry; IPF; NK cells; Regulatory T cells; Th17 cells

Indexed keywords

ACETYLCYSTEINE; CD3 ANTIGEN; CD4 ANTIGEN; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL COMPARTMENTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MALE; MIDDLE AGED; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TH17 CELL;

FLOW CYTOMETRY; IPF; NK CELLS; REGULATORY T CELLS; TH17 CELLS;

AGED; ANTIGENS, CD3; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-17; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; NATURAL KILLER T-CELLS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84894669317     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.12.003     Document Type: Article

References (41)

1. Raghu G., Weycker D., Edelsberg J., Bradford W.Z., Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:810-816.
2. Ozawa Y., Suda T., Naito T., Enomoto N., Hashimoto D., Fujisawa T., et al. Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology 2009, 14:723-728. 10.1111/j.1440-1843.2009.01547.x.
3. Selman M., Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 2002, 3:3.
4. King T.E., Schwarz M.I., Brown K., Tooze J.A., Colby T.V., Waldron J.A., et al. Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001, 164:1025-1032.
5. Bocchino M., Agnese S., Fagone E., Svegliati S., Grieco D., Vancheri C., et al. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One 2010, 5:e14003.
6. + regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500.
7. Baratelli F., Lee J.M., Hazra S., Lin Y., Walser T.C., Schaue D., et al. PGE2 contributes to TGF-β induced T regulatory cell function in human non-small cell lung cancer. Am J Transl Res 2010, 2:356-367.
8. Wilke C.M., Bishop K., Fox D., Zou W. Deciphering the role of Th17 cells in human disease. Trends Immunol 2011, 32:603-611.
9. Martin-Orozco N., Muranski P., Chung Y., Yang X.O., Yamazaki T., Lu S., et al. Th17 cells promote cytotoxic T cell activation in tumor immunity. Immunity 2009, 31:787-798.
10. Kryczek I., Wei S., Szeliga W., Vatan L., Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009, 114:357-359.
11. Vancheri C., Failla M., Crimi N., Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J 2010, 35:496-504.
12. Feghali-Bostwick C.A., Tsai C.G., Valentine V.G., Kantrow S., Stoner M.W., Pilewski J.M., et al. Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis. J Immunol 2007, 179:2592-2599.
13. + regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009, 179:1121-1130.
14. Shimizu Y., Dobashi K., Endou K., Ono A., Yanagitani N., Utsugi M., et al. Decreased interstitial FOXP3(+) lymphocytes in usual interstitial pneumonia with discrepancy of CXCL12/CXCR4 axis. Int J Immunopathol Pharmacol 2010, 23:449-461.
15. Raghu G., Collard H.R., Egan J.J., Martinez F.J., Behr J., Brown K.K., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
16. Guo W. A note on adaptive Bonferroni and Holm procedures under dependence. Biometrika 2009, 96:1012-1018.
17. Gilani S.R., Vuga L.J., Lindell K.O., Gibson K.F., Xue J., Kaminski N., et al. CD28 down-regulation on circulating CD4 T cells is associated with poor prognosis of patients with idiopathic pulmonary fibrosis. PLoS One 2010, 5:e8959.
18. Esposito I., Perna F., Ponticiello A., Perrella M., Gilli M., Sanduzzi A. Natural killer cells in Bal and peripheral blood of patients with idiopathic pulmonary fibrosis (IPF). Int J Immunopathol 2005, 18:541-545.
19. Salagianni M., Baxevanis C.N., Papamichail M., Perez S.A. New insights into the role of NK cells in cancer immunotherapy. Oncoimmunology 2012, 1:205-207.
20. Pilones K.A., Aryankalayil J., Demaria S. Invariant NKT cells as novel targets for immunotherapy in solid tumors. Clin Dev Immunol 2012, 2012:720803. [Epub 2012 October 17]. 10.1155/2012/720803.
21. Boveda-Ruiz D., D'Alessandro-Gabazza C.N., Toda M., Takagi T., Naito M., Matsushima Y., et al. Differential role of regulatory T cells in early and late stages of pulmonary fibrosis. Immunobiology 2013, 218:245-254.
22. Trujillo G., Hartigan A.J., Hogaboam C.M. T regulatory cells and attenuated bleomycin-induced fibrosis in lungs of CCR7-/- mice. Fibrogenesis Tissue Repair 2010, 3:18. 10.1186/1755-1536-3-1.
23. + T cells. J Leuk Biol 2009, 86:1427-1437.
24. Mack D.G., Lanham A.M., Falta M.T., Palmer B.E., Maier L.A. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med 2010, 181:1241-1249.
25. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006, 203:359-370.
26. Idali F., Wahlström J., Müller-Suur C., Eklund A., Grunewald J. Analysis of regulatory T cells associated forkhead fox P3 expression in the lungs of patients with sarcoidosis. Clin Exp Immunol 2008, 152:127-137.
27. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol 2005, 175:8392-8400.
28. + regulatory T cells in systemic lupus erythematosus. Rheumathology 2008, 47:789-794.
29. Wilkie C.A., Bishop K., Fox D., Zou W. Deciphering the role of Th17 cells in human disease. Cell 2011, 32:603-611.
30. Truchetet M.E., Brembilla N.C., Montanari E., Allanore Y., Chizzolini C. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis Res Ther 2011, 13:R166.
31. Abdulahad W.H., Stegeman C.A., Limburg P.C., Kallenberg C.G.M. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2008, 58:2196-2205.
32. Lo Re S., Dumoutier L., Couillin I., Van Vyve C., Yakoub Y., Uwambayinema F., et al. IL-17A-producing γδT and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis. J Immunol 2010, 184:6367-6377.
33. Sfanos K.S., Bruno T.C., Maris C.H., Xu L., Thoburn C.J., De Marzo A.M., et al. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 2008, 14:3254-3261.
34. Chi L.J., Lu H.T., Li G.L., Wang X.M., Su Y., Xu W.H., et al. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol 2010, 161:480-489.
35. Maruyama T., Kono K., Mizukami Y., Kawaguchi Y., Mimura K., Watanabe M., et al. Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 2010, 101:1947-1954.
36. Wang J., Cai D., Ma B., Wu G., Wu J. Skewing the balance of regulatory T-cells and T-helper 17 cells in breast cancer patients. J Int Med Res 2011, 39:691-701.
37. Zhao L., Yan J., Wang H.P., Liu R.Y. Imbalance in the Th17/Treg and cytokine environment in peripheral blood of patients with adenocarcinoma and squamous cell carcinoma. Med Oncol 2013, 30:461. [Epub 2013 January 20]. 10.1007/s12032-013-0461-7.
38. Di L., Chen J., Jia M., Hong K., Ruan Y., Liang H., et al. Loss of balance between T helper type 17 and regulatory T cells in chronic human immunodeficiency virus infection. Clin Exp Immunol 2011, 165:363-371.
39. + regulatory T cells and Th17 cells in myasthenia gravis patients. J Neuroimmunol 2010, 225:123-131.
40. Jia S., Li C., Wang G., Yang J., Zu Y. The T helper type 17/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol 2010, 162:131-137.
41. Wang W., Shao S., Jiao Z., Guo M., Xu H., Wang S. The Th17/Treg imbalance and cytokine environmental in peripheral blood of patients with rheumatoid arthritis. Rheumatol Int 2012, 32:887-893. [Epub 2011 January 11]. 10.1007/s00296-010-1710-0.